Bravelle

bravelleIn October of 2015, Ferring Pharmaceuticals quietly initiated a voluntary, class 2 recall of Bravelle® (75 IU dose, injection-method, NDC 55566850506), for reasons of sub-potency. In other words, it did not contain the right amount of active ingredient.

The recall applies to Bravelle® products sold between March 27, 2014 and October 6, 2015. If you or a loved one experienced any of the following losses or injuries you may be entitled to compensation:

  • You spent thousands of dollars on the ineffective Bravelle®.
  • You spent tens of thousands of dollars on fertility procedures (such as in vitro fertilization or IVF) that were ineffective because Bravelle® did not help you adequately make or release eggs.
  • You experienced undue physical pain and suffering and side effects from Bravelle®.
  • You experienced other injuries from your use of Bravelle® such as failed pregnancies and fertilizations.
  • You experienced other related emotional damages as a result of your use of Bravelle®.
  • Loss of your opportunity to have any children because Bravelle® wasted valuable time.

Affected lots were distributed between March 27, 2014, and October 6, 2015. As of now, the following lots have been identified, but other lots may also have been affected:

H15815A-1 (07/31/2015)
H15815B-1 (08/31/2015)
H15815SMA-1 (07/31/2015)
H16998A-1 (08/31/2015)
H16998SMA-1 (08/31/2015)
K10008A-1 (01/31/2016)
K10008A-2 (01/31/2016)
K11813A-1 (01/31/2016)
K11813A-2 (01/31/2016)
K11813B-1 (04/30/2016)
K11813C-1 (04/30/2016)
K13031A-1 (05/31/2016)
K13031B-1 (05/31/2016)
K13031B-2 (05/31/2016)
K13503A-1 (05/31/2016)
K13503B-1 (06/30/2016)
K13503SMA-1 (05/31/2016)
K13512A-1 (06/30/2016)
K13512A-2 (06/30/2016)
K13921A-1 (06/30/2016)
K13921A-2 (06/30/2016)
K13921B-1 (06/30/2016)
K14616A-1 (08/31/2016)
K14616A-2 (08/31/2016)
K15917A-1 (08/31/2016)
K15917SMA-1 (08/31/2016)
K15917SMA-2 (08/31/2016)
K17006AA (09/30/2016)
K18201AA (12/31/2016)
K18202AA (12/31/2016)
L10403AA (12/31/2016)
L10403AB (08/31/2016)
L10840AA (01/31/2017)
L10992AA (01/31/2017)
Expiration Dates listed in Parenthesis

In some cases Ferring Pharmaceuticals has offered to pay victims the purchase price of Bravelle®. Don’t sacrifice your right to a full recovery for all of your damages just because you want a quick payment. You need a lawyer to get you full compensation.

Have a Question?

Please Contact Us using our Contact page
or by calling Toll-Free: (800) 664-1734

Recent Posts about Drugs and Pharmaceuticals

URGENT RECALL: BRAVELLE® FOLLICLE-STIMULATING HORMONE RECALLED FOR LACK OF EFFICACY

URGENT RECALL: BRAVELLE® FOLLICLE-STIMULATING HORMONE RECALLED FOR LACK OF EFFICACY

URGENT RECALL: BRAVELLE® FOLLICLE-STIMULATING HORMONE RECALLED FOR LACK OF EFFICACY In October[...]
Federal Judge Confirms $200 Million Settlement for Victims Injured by Tainted NECC Steroids

Federal Judge Confirms $200 Million Settlement for Victims Injured by Tainted NECC Steroids

Springfield, Mass. - Yesterday, Federal Bankruptcy Judge Henry Boroff ruled in open court confirming[...]
Federal Jury Awards over $9 Billion in Actos Trial

Federal Jury Awards over $9 Billion in Actos Trial

On Monday, a jury in Louisiana awarded Terrence and Susan Allen over $9 Billion (that’s right: $9,[...]
No thumbnail available

FDA Uncovers Wide-Spread Contamination in Weight Loss Products

The FDA has launched an investigation of weight loss products contaminated with undeclared chemica[...]
No thumbnail available

Male Testosterone Supplements Linked to Increased Risk of Heart Attack & Stroke

Abbott Labs is under fire after several users of its Androgel® testosterone replacement drug cla[...]
Unexpected Breast Growth from Risperdal Traumatizes Young Men

Unexpected Breast Growth from Risperdal Traumatizes Young Men

Just before the first trial involving Risperdal® (Risperidone) began in Pennsylvania state court[...]
Andrews Thornton Higgins Razmara Investigates ADHD Medications Linked to Priapism in Men

Andrews Thornton Higgins Razmara Investigates ADHD Medications Linked to Priapism in Men

The FDA warns that a class of medications used to treat attention deficit hyperactivity disorder (AD[...]
No thumbnail available

Andrews Thornton Higgins Razmara Hand-Delivers NECC Bankruptcy Claims

In order to guarantee proper and timely filing of over 150 claims in the New England Compounding[...]